Gautam Patel - Jan 1, 2024 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role: Director
Signature: /s/ Gautam Patel
Stock symbol: AMRX
Transactions as of: Jan 1, 2024
Transactions value $: $0
Form type: 4
Date filed: 1/3/2024, 04:36 PM
Previous filing: Nov 28, 2023
Next filing: May 6, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMRX	Class A Common Stock	Other		-33.5M	-98.89%		374K	Jan 1, 2024	Direct	F1
transaction	AMRX	Class A Common Stock	Gift	$0	+1.6M	+426.94%	$0.00	1.97M	Jan 1, 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person previously controlled an entity (the "Trustee") that serves as the sole trustee of certain trusts (the "Trusts") that hold, in the aggregate, 33,458,067 shares of the Class A Common Stock of the issuer. On January 1, 2024, the reporting person sold to a third party all of the issued and outstanding common stock of the Trustee. In connection therewith, the reporting person also resigned from all positions he previously held with the Trustee, effective as of January 1, 2024. As a result of these transactions, the reporting person no longer has beneficial ownership of any of the shares of Class A Common Stock of the issuer held by any trusts of which the Trustee is the sole trustee.
F2	The reporting person is a beneficiary of one of the Trusts. Following the execution of the transactions described in the preceding footnote, on January 1, 2024, the reporting person received a distribution from such Trust of 1,598,115 shares of the Class A Common Stock of the issuer.

Content

The reporting person previously controlled an entity (the "Trustee") that serves as the sole trustee of certain trusts (the "Trusts") that hold, in the aggregate, 33,458,067 shares of the Class A Common Stock of the issuer. On January 1, 2024, the reporting person sold to a third party all of the issued and outstanding common stock of the Trustee. In connection therewith, the reporting person also resigned from all positions he previously held with the Trustee, effective as of January 1, 2024. As a result of these transactions, the reporting person no longer has beneficial ownership of any of the shares of Class A Common Stock of the issuer held by any trusts of which the Trustee is the sole trustee.

The reporting person is a beneficiary of one of the Trusts. Following the execution of the transactions described in the preceding footnote, on January 1, 2024, the reporting person received a distribution from such Trust of 1,598,115 shares of the Class A Common Stock of the issuer.